Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 16.


Giardiello, M ORCID: 0000-0003-0560-4711, Liptrott, MJ, McDonald, TO ORCID: 0000-0002-9273-9173, Moss, D, Siccardi, M ORCID: 0000-0002-3539-7867, Martin, P, Smith, D, Gurjar, R, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651 (2016) Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nature Communications, 7 (1). 13184-.


Town, AR, Giardiello, M ORCID: 0000-0003-0560-4711, Gurjar, R, Siccardi, M ORCID: 0000-0002-3539-7867, Briggs, ME ORCID: 0000-0003-1474-1267, Akhtar, R ORCID: 0000-0002-7963-6874 and McDonald, TO ORCID: 0000-0002-9273-9173 (2017) Dual-stimuli responsive injectable microgel/solid drug nanoparticle nanocomposites for release of poorly soluble drugs. Nanoscale, 9 (19). pp. 6302-6314.


Neary, M ORCID: 0000-0002-4960-2139, Lamorde, M, Olagunju, A ORCID: 0000-0002-6588-5749, Darin, KM, Merry, C, Byakika-Kibwika, P, Back, DJ, Siccardi, M ORCID: 0000-0002-3539-7867, Owen, A ORCID: 0000-0002-9819-7651 and Scarsi, KK (2017) The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine. CLINICAL PHARMACOLOGY & THERAPEUTICS, 102 (3). pp. 529-536.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, DJ, Rannard, S ORCID: 0000-0002-6946-1097, Meyers, CF, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2018) In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents. Clinical pharmacokinetics, 57 (02). pp. 255-266.


Rajoli, RKR ORCID: 0000-0002-6015-5712 (2017) Investigation of Long-acting Antiretroviral Nanoformulation Pharmacokinetics Using Experimental and Computational Methods. PhD thesis, University of Liverpool.


Swindells, S, Siccardi, M ORCID: 0000-0002-3539-7867, Barrett, SE, Olsen, DB, Grobler, JA, Podany, AT, Nuermberger, E, Kim, P, III, Barry CE, Owen, A ORCID: 0000-0002-9819-7651 et al (show 2 more authors) (2018) Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (2). pp. 125-132.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2016) Long-acting injectable formulations for children and adolescents using PBPK modelling. 11 August 2016, Swansea.


Tatham, L ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Dwyer, AB, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651 (2018) Maraviroc solid drug nanoparticles with improved oral pharmacokinetics. In: CROI, 2018-3-4 - 2018-3-7, Boston MA.


Halamoda-Kenzaoui, B, Vandebriel, RJ, Howarth, A ORCID: 0000-0003-2288-1745, Siccardi, M ORCID: 0000-0002-3539-7867, David, CAW ORCID: 0000-0001-8504-2354, Liptrott, NJ ORCID: 0000-0002-5980-8966, Santin, M, Borgos, SE, Bremer-Hoffmann, S and Caputo, F (2021) Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation. JOURNAL OF CONTROLLED RELEASE, 336. pp. 192-206.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, AT, Moss, DM, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2018) Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (8). pp. 937-944.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2014) Optimisation of Intramuscular Sustained Release-Nano-Formulations Using In Silico Modelling. [Poster]


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2016) Predicting Utility of Long-Acting Injectables in Paediatric Patients With PBPK Models. [Poster]


Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, A, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867 (2016) Simulation of long-acting administration of antituberculosis agents using pharmacokinetic modelling. 24 October 2016, Liverpool.


Tatham, L ORCID: 0000-0001-9448-8876, Dwyer, AB, Savage, Alison C ORCID: 0000-0002-5312-9946, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651 (2018) Towards a Long-Acting Injectable (LAI) Formulation For Maraviroc. In: CROI, 2018-3-4 - 2018-3-7, Boston MA.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651, Donnelly, R and Siccardi, M ORCID: 0000-0002-3539-7867 (2017) Transdermal delivery with microneedle patches using in silico modelling. 10 August 2017, Belfast.


Siccardi, M ORCID: 0000-0002-3539-7867, Dickinson, L ORCID: 0000-0001-5557-9396 and Owen, A ORCID: 0000-0002-9819-7651 (2016) Validation of computational approaches for antiretroviral dose optimization. Antimicrobial Agents and Chemotherapy, 60 (6). pp. 3838-3839.

This list was generated on Mon Jan 22 02:56:25 2024 GMT.